Verified email-pattern data for Anticonvulsant Drug Development (Add) Program is currently limited. You can still use the company insights and contact sections below.
The project uses preclinical seizure models and neuroscience techniques to help develop new antiepileptic agents. Some 800-1000 novel compounds per year are evaluated against conventional drugs for anticonvulsant efficacy and potency, neurotoxicity, effect on liver function, and mechanism of action. Promising compounds, which exhibit a high level and/or unusual spectrum of anticonvulsant activity with superior therapeutic potential, are selected for detailed toxicology studies and subsequent clinical trials in epileptic patients. The project has been continually funded since 1975 and every new anticonvulsant introduced to clinical use in the USA during the past 40 years has been evaluated in this research program.
The program is an integral part of the Department of Pharmacology and Toxicology and, as such, provides a site for research training of undergraduate students, departmental graduate students and postdoctoral fellows. Faculty aligned with the program also provide instruction to professional students in the College of Pharmacy and the School of Medicine.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 30 S 2000 E, Salt Lake City,utah 84112,united States
- Industry
- Research Services
- Website
- https://pharmacy.utah.edu/add/
- Keywords
- Epilepsy and neuroscience.
- HQ
- Salt Lake City, Utah
Anticonvulsant Drug Development (Add) Program Questions
Anticonvulsant Drug Development (ADD) Program's website is https://pharmacy.utah.edu/add/
Anticonvulsant Drug Development (ADD) Program's LinkedIn profile is https://www.linkedin.com/company/add-program-utah
Anticonvulsant Drug Development (ADD) Program has
5 employees.
View email and phone details for 5
employees at Anticonvulsant Drug Development (ADD) Program.
Anticonvulsant Drug Development (ADD) Program's industry is
Research Services
Anticonvulsant Drug Development (ADD) Program's top competitors are
Sierra-At-Tahoe Resort,
Anilocus, Inc.,
Agbt - Advances In Genome Biology And Technology,
Arup Laboratories,
A Little Bird, Llc,
Neuralink.
Anticonvulsant Drug Development (ADD) Program's categories are Research Services
Anticonvulsant Drug Development (ADD) Program's founding year is 1975
Explore related pages
Anticonvulsant Drug Development (ADD) Program company profile
Anticonvulsant Drug Development (ADD) Program management contacts
Related company profiles:
Companies like Anticonvulsant Drug Development (ADD) Program
Top Anticonvulsant Drug Development (ADD) Program Employees
-
Peter J. West
Research Associate Professor And Co-Investigator At Anticonvulsant Drug Development (Add) Program
Salt Lake City, Utah, United States, United States3comcast.net, lancasterhistory.org, utah.edu8 +180155XXXXX
-
-
Christine Ligouri
Sr. Research Analyst
Sandy, Utah, United States, United States -
Vanja Panic, PhD
Assistant Director, Operations
Salt Lake City Metropolitan Area, United States
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.